Frontierby eninvs

Language: EN · RU

← Region

Merck & Co., Inc. (MRK) USD

Sector: Health care

US_MRK

Price chart

130.48 USDDay 2.36%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
130.48 USD · 2.36%
Market cap
327.1 bn USD

Growth

Δ revenue y/y
4.9%
Δ EBITDA y/y
10.1%

Multiples

P/E (LTM)
36.6x
3y avg: 14.5x
P/B (FY)
6.2x
P/E (ann.)
<0
EV/EBITDA (LTM)
13.8x
3y avg: 11.2x
EV/EBITDA (ann.)
15.7x

Cash return

Dividend yield
2.6%
FCF yield (LTM)
-1.5%

Value creation

fundamental value/yr, % of market cap
Value created / year
+29.2%
↓ details

Liquidity

Daily turnover (US listing)
780.3 mln USD

Shares: yahoo_fundamentals_timeseries/MRK

Financial results

Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueB USDOperating profitB USDD&AB USDEBITDAB USDNet profitB USDOperating CFB USDCapex + M&AB USDAssetsB USDEquityB USDROE (annualized)Net debtB USDSource
2026-03-31Q1 2026 (3M)OK16.3
y/y 4.9%
—
y/y —
0.6
y/y 15.7%
—
y/y —
-4.2
y/y -183.5%
3.9-9.8128.7
y/y 11.8%
45.9
y/y -5.1%
-34.4%43.4Link
2025-12-31Q4 2025 (3M)OK16.4
y/y 5.0%
3.4
y/y -18.0%
4.3
y/y 46.9%
7.7
y/y 8.8%
3.0
y/y -20.8%
2.9-11.1136.9
y/y 16.9%
52.6
y/y 13.6%
35.0%36.0Link
2025-09-30Q3 2025 (3M)OK17.3
y/y 3.7%
6.7
y/y 64.9%
0.5
y/y -3.8%
7.3
y/y 56.7%
5.8
y/y 83.2%
7.8-1.0129.5
y/y 10.2%
51.9
y/y 16.5%
15.3%23.2Link
2025-06-30Q2 2025 (3M)OK15.8
y/y -1.9%
5.0
y/y -16.8%
0.5
y/y 0.0%
5.5
y/y -15.4%
4.4
y/y -18.8%
3.3-0.8117.5
y/y 4.3%
49.0
y/y 12.4%
36.4%26.8Link
2025-03-31Q1 2025 (3M)OK15.5
y/y -1.6%
5.9
y/y 4.1%
0.5
y/y -1.8%
6.4
y/y 3.6%
5.1
y/y 6.7%
2.5-1.3115.1
y/y 8.8%
48.3
y/y 19.7%
42.9%25.6Link
2024-12-31Q4 2024 (3M)OK15.6
y/y 6.8%
4.2
y/y 288.0%
2.9
y/y 16.8%
7.1
y/y 2397.2%
3.7
y/y 405.3%
3.5-0.9117.1
y/y 9.8%
46.3
y/y 23.2%
37.7%24.6Link
2024-09-30Q3 2024 (3M)OK16.7
y/y 4.4%
4.1
y/y -27.2%
0.6
y/y 22.3%
4.6
y/y -23.5%
3.2
y/y -33.5%
9.3-1.4117.5
y/y 10.1%
44.5
y/y 7.9%
9.6%23.5Link
2024-06-30Q2 2024 (3M)OK16.1
y/y 7.2%
6.0
y/y —
0.5
y/y 21.6%
6.5
y/y —
5.5
y/y —
5.6-0.8112.6
y/y 7.8%
43.6
y/y 12.6%
52.0%26.4Link
2024-03-31Q1 2024 (3M)OK15.8
y/y 8.9%
5.7
y/y 55.3%
0.5
y/y 14.1%
6.2
y/y 50.8%
4.8
y/y 68.8%
3.1-1.6105.8
y/y -1.8%
40.4
y/y -13.8%
48.9%28.6Link
2023-12-31Q4 2023 (3M)OK14.6
y/y —
-2.2
y/y —
2.5
y/y —
0.3
y/y —
-1.2
y/y —
0.2-1.0106.7
y/y —
37.6
y/y —
0.9%29.2Link
2023-09-30Q3 2023 (3M)OK16.0
y/y —
5.6
y/y —
0.5
y/y —
6.1
y/y —
4.7
y/y —
7.7-0.9106.7
y/y —
41.2
y/y —
15.8%26.1Link
2023-06-30Q2 2023 (3M)OK15.0
y/y —
-5.2
y/y —
0.4
y/y —
-4.7
y/y —
-6.0
y/y —
3.7-10.3104.5
y/y —
38.7
y/y —
-55.9%30.5Link
2023-03-31Q1 2023 (3M)OK14.5
y/y —
3.6
y/y —
0.4
y/y —
4.1
y/y —
2.8
y/y —
1.3-2.3107.8
y/y —
46.8
y/y —
—20.4Link

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

-5 00005 00010 00015 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Year-over-year change

-25%0%25%50%2023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Cash flow

FCF ($ mln)

-10 000-5 00005 00010 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Net debt / cash ($ mln)

010 00020 00030 00040 0002023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q42026 q1

Fundamental value creation

Value the company creates per year, as a % of market cap

Value created per year: +29.5%

How this was calculated
1. EBITDA growth (latest quarter YoY, annualised)
[EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2025-12-31 vs 2024-12-31)
= (5 886 − 4 170) × 4.26
7 313
2. Current EV/EBITDA (LTM)
(Market cap + Net debt) ÷ EBITDA (LTM)
= (327 113 + 43 415) ÷ 25 085
14.8x
3. Target multiple
(Current EV/EBITDA + 12) ÷ 2
= (14.8 + 12) ÷ 2
13.4x
4. Cash flow (balance method, LTM)
Net-debt reduction + dividends + buybacks − equity issuance
= -11 388 + 6 158 + 3 832 − 0
-1 398
5. Value created per year
(EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap
= (7 313 × 13.4 + -1 398) ÷ 327 113
+29.5%

Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.

Revenue growth & acceleration

Growth decelerating ▼
Last-year revenue growth +1% vs +7% the year before — a -5.4 pp move. 3-year CAGR +3%.
revenue growth by year: 2023 +1% · 2024 +7% · 2025 +1%
The growth-acceleration signal behind the GARP+acceleration strategy — it favours companies whose revenue growth is speeding up and flags those slowing down (the second derivative of growth).

EV/EBITDA — daily history

Current 14.3x · 3-year average 16.1x

EV/EBITDA3-year 75th pct

Dividends

Paid (completed)

DatePer shareDetailsStatusSource
2026-06-150.85 USDEx-dividend: 0.85 USD per sharePaidYahoo Finance (ex-div)
2026-03-160.85 USDEx-dividend: 0.85 USD per sharePaidYahoo Finance (ex-div)
2025-12-150.85 USDEx-dividend: 0.85 USD per sharePaidYahoo Finance (ex-div)
2025-09-150.81 USDEx-dividend: 0.81 USD per sharePaidYahoo Finance (ex-div)
2025-06-160.81 USDEx-dividend: 0.81 USD per sharePaidYahoo Finance (ex-div)
2025-03-170.81 USDEx-dividend: 0.81 USD per sharePaidYahoo Finance (ex-div)
2024-12-160.81 USDEx-dividend: 0.81 USD per sharePaidYahoo Finance (ex-div)
2024-09-160.77 USDEx-dividend: 0.77 USD per sharePaidYahoo Finance (ex-div)
2024-06-170.77 USDEx-dividend: 0.77 USD per sharePaidYahoo Finance (ex-div)
2024-03-140.77 USDEx-dividend: 0.77 USD per sharePaidYahoo Finance (ex-div)
2023-12-140.77 USDEx-dividend: 0.77 USD per sharePaidYahoo Finance (ex-div)
2023-09-140.73 USDEx-dividend: 0.73 USD per sharePaidYahoo Finance (ex-div)
2023-06-140.73 USDEx-dividend: 0.73 USD per sharePaidYahoo Finance (ex-div)
2023-03-140.73 USDEx-dividend: 0.73 USD per sharePaidYahoo Finance (ex-div)
2022-12-140.73 USDEx-dividend: 0.73 USD per sharePaidYahoo Finance (ex-div)
2022-09-140.69 USDEx-dividend: 0.69 USD per sharePaidYahoo Finance (ex-div)
2022-06-140.69 USDEx-dividend: 0.69 USD per sharePaidYahoo Finance (ex-div)
2022-03-140.69 USDEx-dividend: 0.69 USD per sharePaidYahoo Finance (ex-div)
2021-12-140.69 USDEx-dividend: 0.69 USD per sharePaidYahoo Finance (ex-div)
2021-09-140.65 USDEx-dividend: 0.65 USD per sharePaidYahoo Finance (ex-div)

KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).

Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)

Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Merck & Co., Inc. (MRK) — from primary filings.

Global pharma—oncology, vaccines, hospital acute care, and animal health.

Frequently asked questions

What is Merck & Co., Inc. (MRK)'s P/E ratio?
Merck & Co., Inc. (MRK) trades at a P/E of 36.6x (price to trailing 12-month earnings).
What is Merck & Co., Inc. (MRK)'s EV/EBITDA?
Merck & Co., Inc. (MRK) trades at 13.8x EV/EBITDA.
What is Merck & Co., Inc. (MRK)'s P/B ratio?
Merck & Co., Inc. (MRK) trades at a P/B of 6.2x.
What is Merck & Co., Inc. (MRK)'s dividend yield?
Merck & Co., Inc. (MRK)'s trailing 12-month dividend yield is 2.6%.
What is Merck & Co., Inc. (MRK)'s return on equity (ROE)?
Merck & Co., Inc. (MRK)'s ROE is -34.4%.
What is Merck & Co., Inc. (MRK)'s market capitalization?
Merck & Co., Inc. (MRK)'s market cap is 327.1 bn USD.